Clinical Trial

Evaluation of Endothelial Glycocalyx in the Surgical Resuscitation of Major Burn Patients

Study acronym: GlycoBURN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 1, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this observational study is to examine whether Endotheliopathy of Trauma (EoT) is present in severely burned patients and how it is affected by burn debridement surgery. The main questions it aims to answer are: * Do severely burned patients present with EoT before undergoing burn debridement surgery? * Does the surgical intervention worsen EoT, leading to increased postoperative syndecan 1 (sdc 1) levels compared to preoperative levels? Participants will: * Undergo debridement surgery where the total area of debrided and donor sites covers 20% or more of the Total Body Surface Area (TBSA). * Have their sdc 1 levels measured before and after surgery. * Have perioperative factors analyzed to assess their impact on endothelial damage and glycocalyx functionality. This study aims to provide insight into how surgical resuscitation affects the endothelial glycocalyx in severely burned patients.
Trial Details
NCT Number NCT06670248
Lead Sponsor Hospital Universitari Vall d'Hebron Research Institute
Conditions Syndecan 1, Severe Burn, Endotheliopathy of Trauma, Endothelial Glycocalyx, Hemorrhagic Shock, Postoperative Complications
Enrollment 40 participants
Start Date 2024-03-05
Primary Completion 2026-03 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2024-11-01